Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) EBT Margin (2016 - 2025)

Historic EBT Margin for Usana Health Sciences (USNA) over the last 16 years, with Q3 2025 value amounting to 0.84%.

  • Usana Health Sciences' EBT Margin fell 84500.0% to 0.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.24%, marking a year-over-year decrease of 55000.0%. This contributed to the annual value of 8.94% for FY2024, which is 21900.0% down from last year.
  • As of Q3 2025, Usana Health Sciences' EBT Margin stood at 0.84%, which was down 84500.0% from 7.98% recorded in Q2 2025.
  • Over the past 5 years, Usana Health Sciences' EBT Margin peaked at 16.12% during Q3 2021, and registered a low of 0.84% during Q3 2025.
  • In the last 5 years, Usana Health Sciences' EBT Margin had a median value of 11.08% in 2022 and averaged 10.37%.
  • In the last 5 years, Usana Health Sciences' EBT Margin skyrocketed by 20300bps in 2023 and then tumbled by -84500bps in 2025.
  • Over the past 5 years, Usana Health Sciences' EBT Margin (Quarter) stood at 14.71% in 2021, then crashed by -32bps to 10.0% in 2022, then increased by 20bps to 12.04% in 2023, then crashed by -59bps to 4.88% in 2024, then tumbled by -83bps to 0.84% in 2025.
  • Its EBT Margin was 0.84% in Q3 2025, compared to 7.98% in Q2 2025 and 6.71% in Q1 2025.